September 19, 2022

For those who prefer to read the Summer 2022 issue's feature article in Portuguese...

September 19, 2022/ JFR

Na prática médica e especificamente na prática cefaliátrica, as seguradoras geralmente requerem autorizações prévias (AP) antes de reembolsar ou pagar o paciente ou o provedor de serviços como a clínica de exames ou de tratamento como no botox…

September 16, 2022

Dancing With the Devil: A Physician’s Perspective

September 16, 2022/ JFR

In the practice of medicine generally and headache medicine specifically, insurers often require “prior authorization” (PA) before they will reimburse…

September 15, 2022

Mono-therapy vs Polytherapy: When is Two Better Than One?

September 15, 2022/ JFR

In the last issue of this magazine we focused on the relative attractiveness of the “old” medications for migraine treatment compared to the newer “designer drugs”…

September 14, 2022

What’s New? Developments from the front lines of migraine research

September 14, 2022/ JFR

Atogepant (Qulipta): an attractive new option for suppressing chronic migraine
Migraine “Rescue”: don’t like self-injection? how about a nasal spray?
Alzheimer’s, Dementia and Migraine: where things presently stand
Migraine and Sex: an update and a stimulating(!) new avenue of research

September 12, 2022

Lagniappe: A Gift: The Chesapeake and Ohio (C&O) Canal

September 12, 2022/ JFR

The Chesapeake and Ohio (C&O) Canal was conceived by George Washington, the ever-entrepreneurial Father of Our Country, as a means of…

September 11, 2022

Migraine Treatment of the Month: Divalproex sodium: an oldie... but a goodie?

September 11, 2022/ JFR

In 1978 valproic acid (also known as sodium valproate or divalproex sodium) was approved by the FDA for seizure prevention…

September 10, 2022

Migraine Myth of the Month: The triptans are potentially dangerous drugs

September 10, 2022/ JFR

The first “designer drug” for migraine treatment, injectable sumatriptan (Imitrex), was approved by the FDA for general clinical use in this country in 1992…

September 09, 2022

Doctor on Call: What the heck is “transformed migraine”?

September 09, 2022/ JFR

Sandra, a 37-year-old computer software engineer and mother of three from Colorado Springs, writes:

September 07, 2022

Biographies

September 07, 2022/ JFR

It is my great pleasure to announce to our readership that Drs. Robert Cowan and Richard Lipton have accepted my invitations to become senior editorial advisers.

September 06, 2022

Messages to the Editor

September 06, 2022/ JFR

Addressing the article entitled “Migraine’s Supply/Demand Problem” in our Spring 2022 issue Ms. Pam Nice writes…

September 05, 2022

Letter from the Editor

September 05, 2022/ JFR

After a gorgeous spring, western Maryland gave way to an equally gorgeous summer…

Articles

Latest News